XKEM KA-BOOOOOOOOOOOOOOOOOOOOOOOOOOOOOOOOOOOOOM
(COMTEX) B: Early Stock Market Alerts for Friday, June 25, 2004: XKEM, BSX
TSM, AGRD ( PRIMEZONE )
B: Early Stock Market Alerts for Friday, June 25, 2004: XKEM, BSX, TSM, AGRD ( P
IMEZONE )
WESTON, Fla., Jun 25, 2004 (PRIMEZONE via COMTEX) -- TheSUBWAY.com names the
following stocks to its Stock Alerts List: Xechem International, Inc.
(OTCBB:XKEM), Boston Scientific Corporation (NYSE:BSX), Taiwan Semiconductor
Mfg. Co. (NYSE:TSM), AuGRID Corp. (OTCBB:AGRD).
Xechem International, Inc. (OTCBB:XKEM) and Xechem, Inc. filed an antitrust suit
against Bristol-Myers Squibb Company in the U.S. District Court seeking treble
damages in connection with BMS' alleged engagement in a series of unlawful acts
to delay competition in generic versions of paclitaxel. The lawsuit had been
initially dismissed by the District Court on the grounds that the statute of
limitations barred the action.
On June 23, 2004 the US Court of Appeals for the Seventh Circuit, however,
reversed the District Court opinion and determined that the basis for dismissal
was improper. Although there has been no determination on the merits of the
case, Xechem intends to vigorously pursue its claims against BMS.
Xechem International, Inc. is a fully integrated biopharmaceutical company
focusing on phytopharmaceuticals and other proprietary technologies for orphan
diseases. Its principal product under development is NICOSAN(TM)/HEMOXIN(TM),
which has shown efficacy in the treatment of sickle cell disease.
Other stocks highlighted include Taiwan Semiconductor Mfg. Co. (NYSE:TSM):
Market Alerts List, Boston Scientific Corporation (NYSE:BSX): Market Alerts
List, AuGRID Corp. (OTCBB:AGRD): Market Alerts List.
TheSUBWAY.com's Daily Stock Updates:
TheSUBWAY.com highlights stocks that are in the news, have traded high volume,
or experienced a large change in price in recent sessions. The aforementioned
commentary is not meant to be indicative of a "long term" view of any of the
companies listed.
About TheSUBWAY.com:
TheSUBWAY.com, a leader in corporate communications and finance, provides all
investors with a wide-ranging set of financial tools, including original stock
market commentary, stock quotes, interactive charts, portfolio watch, live chat
and message boards, etc., plus the latest news, press releases, investment
opinions, and research reports for all companies highlighted on the site. For
more daily commentary, go to: (http://www.thesubway.com/sub_comm.asp).
All material herein was prepared by Capital Research Group, Inc. (CRG) based
upon information believed to be reliable. The information contained herein is
not guaranteed by CRG to be accurate, and should not be considered to be
all-inclusive. The companies that are discussed in this opinion have not
approved the statements made in this opinion. This opinion contains
forward-looking statements that involve risks and uncertainties. This material
is for informational purposes only and should not be construed as an offer or
solicitation of an offer to buy or sell securities. CRG is not a licensed
broker, broker dealer, market maker, investment banker, investment advisor,
analyst or underwriter. Please consult a broker before purchasing or selling any
securities viewed on: (http://www.thesubway.com) or mentioned herein. CRG has
been compensated by third party shareholders or with cash from the company on
behalf of one or more of the companies mentioned in this opinion. (CRG has not
been compensated but could receive up to one hundred thousand dollars for XKEM.
CRG has purchased approximately eight hundred thousand shares in the open
market) CRG intends to sell its shares. CRG has sold approximately five hundred
thousand shares to date. CRG may sell its shares for less than the target price
given in this opinion. CRG's affiliates, officers, directors and employees may
also have bought or may buy the shares discussed in this opinion and may profit
in the event those shares rise in value. CRG will not advise as to when it
decides to sell and does not and will not offer any opinion as to when others
should sell; each investor must make that decision based on his or her judgment
of the market.
SOURCE: Capital Research Group, Inc
INVESTMENT OPINION
By Staff
CONTACT: Capital Research Group, Inc.
Chuck Tamburello
Tel: (954) 217-8555
Fax: (954) 217-1500
(C) 2004 PRIMEZONE, All rights reserved.
-0-
INDUSTRY KEYWORD: Business Services
SUBJECT CODE: INVESTMENT OPINION
Analyst Recommendations
*** end of story *** |
